The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

Q2 2025 Earnings Call Transcript July 30, 2025 Option Care Health, Inc. beats earnings expectations. Reported EPS is $0.41, ...

Kedrion Biopharma receives US FDA orphan drug designation for Coagadex to treat acquired Factor X deficiency: Fort Lee, New Jersey Thursday, July 31, 2025, 15:00 Hrs [IST] Kedrion ...

Option Care Health reports strong Q2 2025 growth, raises guidance, and highlights advanced care models & payer partnerships.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

In the latest edition of Lunchtime Tourism in the Square Mile, we go inside the Pollocks Toy Museum in Leadenhall Market ...

Experts say the system of EDRDs incentivizes companies to manufacture these drugs due to the high prices that can be charged ...

New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company ...

Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CA ...

ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1) ("ALT5" or the "Company"), a fintech company delivering blockchain-powered payment and trading infrastructure for global merchants and financial ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN ...

A Nigerian man shared how he relocated abroad by hiding inside a ship that took him to Barcelona. He said he was caught and deported after some time.